Envoy Medical (COCH) Free Cash Flow (2021 - 2026)

Envoy Medical has disclosed Free Cash Flow across 6 years of filings, most recently posting -$6.1 million for Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$6.1 million, down 62.45% year-over-year; the trailing twelve-month figure through Mar 2026 was -$20.7 million (down 22.1% YoY), and the FY2025 annual result was -$18.4 million, up 2.9% from the prior year.
• Free Cash Flow came in at -$6.1 million for Q1 2026 at Envoy Medical, down from -$5.9 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $1.0 million in Q3 2023 to a low of -$11.2 million in Q4 2023.
• The 5-year median for Free Cash Flow is -$4.3 million (2025), against an average of -$4.1 million.
• Peak annual rise in Free Cash Flow reached 119.74% in 2023, while the deepest fall reached 910.85% in 2023.
• Envoy Medical's Free Cash Flow stood at -$2.4 million in 2022, then slumped by 361.4% to -$11.2 million in 2023, then soared by 59.19% to -$4.6 million in 2024, then dropped by 28.53% to -$5.9 million in 2025, then retreated by 3.48% to -$6.1 million in 2026.
• The last three Free Cash Flow figures came in at -$6.1 million (Q1 2026), -$5.9 million (Q4 2025), and -$4.3 million (Q3 2025), per Business Quant data.